Dicot Pharma AB | DICOTBT Logo | Annual Report & Investor Relations Data

Dicot Pharma AB | DICOTBT Annual Report & Investor Relations Data

ISIN

SE0013101276

Ticker

DICOTBT

Sector

Health Care

Industry

Pharmaceuticals

Country

Sweden

Year Founded

2018

Dicot Pharma AB (DICOTBT)
Company Overview & Profile

Company Description

Dicot Pharma is developing the drug candidate LIB-01, which is expected to be a potency drug to treat erectile dysfunction and premature ejaculation. Duration of action and fewer side effects are main desired properties. Dicot's main strategy is to develop LIB-01 in-house up to and including clinical phase 2a study, and then in partnership with major pharmaceutical companies to finance and further develop LIB-01 into a registered drug for the world market.

Served Area

Worldwide

Headquarters

S:t Olofsgatan 11A
C 753 21, Uppsala
Sweden

Dicot Pharma AB (DICOTBT)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get Early API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

Request Early Access

Limited spots available. Join now!

Dicot Pharma AB (DICOTBT)
Insider Trading Activity

Date Trading entity / Person Association Trade type Volume
12.09.2024 Tullbacken Aktiebolag Other Buy SEK 40,250.00
10.09.2024 Amandus Jabin Other Sell SEK 4,276,800.00
03.09.2024 Jörgen Larsson Other Other SEK 0.00
02.09.2024 Patrick Lawlor Other Buy SEK 1,158,625.00
02.09.2024 Oskar Hellström Other Buy SEK 1,121,250.00
02.09.2024 Martin Walfisz Other Other SEK 442,830.78
31.08.2024 Bonny Heeren Other Other SEK 550,000.00
30.08.2024 Per-Anders Hedin Other Other SEK 110,000.00
30.08.2024 Erik Markus Näsholm Other Other SEK 42,600.00
30.08.2024 Greger Larsson Other Other SEK 34,080.00

Dicot Pharma AB (DICOTBT)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

Dicot Pharma AB (DICOTBT)
Stock & Investor Information

ISIN

SE0013101276

LEI

549300GX132RSE4OV407

Stock Exchange Listings

Spotlight Exchange

Primary Stock Exchange Listing

View Dicot Pharma AB on main stock exchange

Industry Classification

Dicot Pharma AB (DICOTBT)
Related Companies & Peer Group

ABIVAX Logo

ABIVAX

ABVX

Sector

Health Care

Country

France

ISIN

FR0012333284

Founded

Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …

Addex Therapeutics Ltd Logo

Addex Therapeutics Ltd

ADXN

Sector

Health Care

Country

Switzerland

ISIN

CH0029850754

Founded

2002

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …

AegirBio AB Logo

AegirBio AB

AEGIR

Sector

Health Care

Country

Sweden

ISIN

SE0014401121

Founded

2019

AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …

Alkaloid AD Logo

Alkaloid AD

None

Sector

Health Care

Country

North Macedonia

ISIN

MKALKA101011

Founded

1936

Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …

Antibiotice S.A. Logo

Antibiotice S.A.

ATB

Sector

Health Care

Country

Romania

ISIN

ROATBIACNOR9

Founded

1955

The leading manufacturer of generic drugs in Romania, Antibiotice SA was founded in December 1955. The company was listed on …

AstraZeneca PLC Logo

AstraZeneca PLC

AZN

Sector

Health Care

Country

United Kingdom

ISIN

GB0009895292

Founded

1999

We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science …